Allianz Asset Management
TTOO

Allianz Asset Management’s T2 Biosystems, Inc TTOO Stock Holding History

Allianz Asset Management’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-97
Closed -$811K – 2830
2019
Q2 		$811K Hold
97
– – ﹤0.01% 2209
2019
Q1 		$1.28M Hold
97
– – ﹤0.01% 2007
2018
Q4 		$1.47M Sell
97
-5
-5% -$117K ﹤0.01% 1882
2018
Q3 		$3.79M Buy
102
+27
+36% +$889K ﹤0.01% 1686
2018
Q2 		$2.92M Buy
+75
New +$2.85M ﹤0.01% 1777

Other funds holding TTOO

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Allianz Asset Management's TTOO Position: Q3 2019 in Review

Allianz Asset Management sold out of T2 Biosystems, Inc (TTOO) in Q3 2019, closing a stake of 97 shares — an estimated $811K sold.

Allianz Asset Management first reported a position in TTOO in Q2 2018 and held it in 5 quarters. The position peaked at $3.79M in Q3 2018. 48 funds tracked by Wall St. Rank hold TTOO as of Q3 2019.

  • Allianz Asset Management reported no remaining T2 Biosystems, Inc position as of Q3 2019 after selling out during the quarter.
  • Allianz Asset Management sold 97 T2 Biosystems, Inc shares in Q3 2019, an estimated $811K.
  • Allianz Asset Management first reported a position in T2 Biosystems, Inc in Q2 2018 and held it in 5 quarters.
  • Allianz Asset Management's T2 Biosystems, Inc position peaked at $3.79M in Q3 2018.
  • 48 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q3 2019.

Based on Allianz Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.